Olsalazine Sodium - search results

United States - English - NLM (National Library of Medicine)

dipentum- olsalazine sodium capsule, gelatin coated

meda pharmaceuticals inc. - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - olsalazine sodium 250 mg - dipentum is indicated for the maintenance of remission of ulcerative colitis in adult patients who are intolerant of sulfasalazine. dipentum is contraindicated in patients with known or suspected hypersensitivity to salicylates, aminosalicylates or their metabolites, or to any of the excipients in dipentum.

United States - English - NLM (National Library of Medicine)

dipentum- olsalazine sodium capsule, gelatin coated

carilion materials management - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - olsalazine sodium 250 mg - olsalazine is indicated for the maintenance of remission of ulcerative colitis in patients who are intolerant of sulfasalazine. hypersensitivity to olsalazine, other salicylates, or any of the excipients. none reported. drug dependence has not been reported with chronic administration of olsalazine.

United States - English - NLM (National Library of Medicine)

dipentum- olsalazine sodium capsule, gelatin coated

carilion materials management - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - olsalazine sodium 250 mg - indications and usage: olsalazine is indicated for the maintenance of remission of ulcerative colitis in patients who are intolerant of sulfasalazine. contraindications: hypersensitivity to olsalazine, other salicylates, or any of the excipients. drug abuse and dependency: abuse: none reported. dependence: drug dependence has not been reported with chronic administration of olsalazine.

United States - English - NLM (National Library of Medicine)

dipentum olsalazine sodium capsule gelatin coated

alaven pharmaceutical llc - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - olsalazine sodium 250 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

dipentum olsalazine sodium 500mg tablet bottle

atnahs pharma australia pty ltd - olsalazine sodium, quantity: 500 mg - tablet, uncoated - excipient ingredients: povidone; crospovidone; colloidal anhydrous silica; magnesium stearate; ethanol - indications: treatment of ulcerative colitis in patients intolerant of sulphasalazine.

United States - English - NLM (National Library of Medicine)

dipentum olsalazine sodium capsule

ucb, inc. - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - 250 mg